CHIH-HUNG WANGCHENG-YI WUWAN-CHING LIENKAO-LANG LIUHSIU-PO WANGYAO-MING WUSHYR-CHYR CHEN2019-10-162019-10-162019-050929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/426790Percutaneous cholecystostomy (PC) is an effective treatment for severe acute cholecystitis (AC). Guidelines recommend PC as rescue therapy for patients with mild or moderate AC who do not receive emergent cholecystectomy. This study aims to investigate whether PC could be a first-line treatment for these patients.enCholecystectomy; Cholecystitis; Cholecystostomy[SDGs]SDG3antibiotic agent; antiinfective agent; acute cholecystitis; adult; aged; antibiotic therapy; Article; cholecystectomy; clinical outcome; cohort analysis; human; intermethod comparison; long term care; major clinical study; medical record review; middle aged; outcome assessment; percutaneous cholecystostomy; retrospective study; short course therapy; acute cholecystitis; adverse event; cholecystectomy; cholecystostomy; comparative study; female; length of stay; male; mortality; multivariate analysis; patient selection; postoperative complication; sepsis; severity of illness index; statistical model; time factor; treatment outcome; very elderly; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cholecystectomy; Cholecystitis, Acute; Cholecystostomy; Female; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Patient Selection; Postoperative Complications; Retrospective Studies; Sepsis; Severity of Illness Index; Time Factors; Treatment Outcomejournal article10.1016/j.jfma.2018.09.018302939282-s2.0-85054532271WOS:000465446800010https://api.elsevier.com/content/abstract/scopus_id/85054532271